Gene · 708
C1QBP: complement C1q binding protein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. C1QBP: complement C1q binding protein. Genes, record 708. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/708
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q07021 | Complement component 1 Q subcomponent-binding protein, mitochondrial | 282 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents82
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 41961 | Q07021 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 638 | Q07021 | Espacenet |
| WO 2025235563 A1 | 2025-11-13 | 24 | Q07021 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 638 | Q07021 | Espacenet |
| WO 2024240908 A1 | 2024-11-28 | 12 | Q07021 | Espacenet |
| JP 2023123507 A | 2023-09-05 | 318 | Q07021 | Espacenet |
| US 11512110 B2 | 2022-11-29 | 19 | Q07021 | Espacenet |
| JP 2022546431 A | 2022-11-04 | 77 | Q07021 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 19314 | Q07021 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 122285 | Q07021 | Espacenet |
1 to 10 of 82
See all 82 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,264
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | C1QBP papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 7 | 2025 |
| ZIAHL006223 | The role of the intracellular complement system - the complosome - in Th1 biology | 5 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| T32AI007046 | Infectious Diseases Training Program | 4 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 3 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 3 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 3 | 2025 |
| P01AI063302 | The intersection of innate and adaptive immunity to intracellular pathogens | 2 | 2025 |
1 to 10 of 1,264Source NIH's project files
See all 1,264 nih grantsPapers2,456
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteins from platelet-enriched preparations as candidate biomarkers for major depressive disorder: An exploratory proteomic study. | J Affect Disord | 2027 | 42826767 | PubTator, text mining | PubMed |
| Complement C1q-binding protein at the host-protozoan interface: knowns and unknowns. | Trends Parasitol | 2026 | 42481243 | PubTator, text mining | PubMed |
| 1D-2D hybrid based electrochemical sensor for nano-architected sensing of ASFV p32 - an early phosphoprotein. | Biosens Bioelectron | 2026 | 42425003 | PubTator, text mining | PubMed |
| Inhibition of Pax6 sumoylation suppresses the tumorigenicity of pancreatic cancer cells. | Cell Death Differ | 2026 | 42342900 | PubTator, text mining | PubMed |
| CHCHD2 and CHCHD10 promoted autophagic clearance of protein aggregates via GABARAPs. | Autophagy | 2026 | 42183628 | PubTator, text mining | PubMed |
| Unveiling C1QBP: A New Guardian of Dopaminergic Neuron in Parkinson's disease by targeting ULK1 to promote mitophagy and maintain mitochondrial function. | Free Radic Biol Med | 2026 | 42176906 | PubTator, text mining | PubMed |
| Enhancing immune-mediated cancer cell engulfment through biophysical techniques: an in-silico investigation focusing on the peptide-mediated disruption of a C1q-gC1qR(p33) interaction. | J Biomol Struct Dyn | 2026 | 42117492 | PubTator, text mining | PubMed |
| Polysaccharide-Rich Herbal Formula Attenuates Skin Aging and Oxidative Stress in VCD-Induced Menopause Models via Regulation of AQP-3, C1QBP, and K19. | Rejuvenation Res | 2026 | 41958012 | PubTator, text mining | PubMed |
| Spatial multiomics profiling reveals ZFP36-mediated immunometabolic reprogramming in bladder cancer. | Proc Natl Acad Sci U S A | 2026 | 41950100 | PubTator, text mining | PubMed |
| Unveiling the mysteries of C1QBP in gynecological tumors (Review). | Mol Clin Oncol | 2026 | 41929232 | PubTator, text mining | PubMed |
1 to 10 of 2,456
See all 2,456 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/708
GET https://conductscience.org/api/genes/v1/708/patents?page=2